A professor of biomedical materials engineering science at the Inamori School of Engineering at Alfred University (Alfred, NY), has done research showing that the risk of bone loss associated with osteoporosis can be predicted using a patient?s toenail clipping and Raman spectroscopy.
Mark Towler, a professor of biomedical materials engineering science at the Inamori School of Engineering at Alfred University (Alfred, NY), has done research showing that the risk of bone loss associated with osteoporosis can be predicted using a patient’s toenail clipping. Towler’s test, the Bone Quality Test (BQT) uses Raman spectroscopy done at the point-of-care.
The BQT involves aiming a 785 nm laser beam with power up to 400 mW at a toenail clipping from a subject. The information recorded from the laser beam evaluates the presence of certain proteins in the nail clipping, measuring the quality of the protein phase of the subject’s bones.
Towler noticed that osteoporosis patients saw improved strength and appearance in their nails after taking medication for osteoporosis. Raman spectroscopy analyses showed differences in the protein structures between the nails of healthy patients and those with osteoporosis.
Crescent Diagnostics (Dublin, Ireland), which Towler co-founded in 2004, hopes to launch the BQT test within a year in Europe and expand into the U.S. market in the next 18 months, pending U.S. FDA approval.
An Interview with AES Mid-Career Award Recipient Jason Dwyer
July 25th 2024Jason Dwyer of the University of Rhode Island has been named the recipient of the American Electrophoresis Society’s Mid-Career Award, which honors exceptional contributions to the field of electrophoresis, microfluidics, and related areas by an individual who is currently in the middle of their career.
Glucose's Impact on Brain Cancer Cells Unveiled Through Raman Imaging
July 25th 2024Researchers have used Raman spectroscopy and chemometric methods to reveal how glucose affects normal and cancerous brain cell metabolism. Their findings highlight specific biomarkers that can distinguish metabolic changes, potentially aiding in cancer research and treatment.